Nachman Norwood & Parrott’s ICU Medical ICUI Stock Holding History

Nachman Norwood & Parrott’s Portfolio ICUI Stock Details ICUI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-55	Closed	-$10K	–	618
2020 Q3	$10K	Buy	+55	New	+$10.4K	﹤0.01%	756

Other funds holding ICUI

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FPP

Findlay Park Partners London, United Kingdom $7.17B AUM 17.27% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nitorum Capital New York $114M AUM 17.21% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Nachman Norwood & Parrott's ICUI Position: Q4 2020 in Review

Nachman Norwood & Parrott sold out of ICU Medical (ICUI) in Q4 2020, closing a stake of 55 shares — an estimated $10K sold.

Nachman Norwood & Parrott first reported a position in ICUI in Q3 2020 and held it in 1 quarter. The position peaked at $10K in Q3 2020. 284 funds tracked by Wall St. Rank hold ICUI as of Q4 2020.

Nachman Norwood & Parrott reported no remaining ICU Medical position as of Q4 2020 after selling out during the quarter.
Nachman Norwood & Parrott sold 55 ICU Medical shares in Q4 2020, an estimated $10K.
Nachman Norwood & Parrott first reported a position in ICU Medical in Q3 2020 and held it in 1 quarter.
Nachman Norwood & Parrott's ICU Medical position peaked at $10K in Q3 2020.
284 funds tracked by Wall St. Rank held ICU Medical as of Q4 2020.

Based on Nachman Norwood & Parrott's 13F filing for Q4 2020, filed 19 Jan 2021.